The name of the base system (platform): | Artificial intelligence (AI, Artificial intelligence, AI) |
Developers: | Digital Oncomorphologist (PathVision.ai) |
Branches: | Pharmaceuticals, Medicine, Healthcare |
The main articles are:
- Cancer diagnosis
- Prostate (prostate) cancer
- Artificial Intelligence in Medicine
- Artificial intelligence in radiology
2024: Obtaining a certificate from Roszdravnadzor
Roszdravnadzor registered an online PathVision.ai platform that allows application AI for diagnostics acinar adenocarcinoma, the most common subtype. prostate cancer Clinical trials conducted on the basis NMHC named after Pirogov confirmed the overall diagnostic accuracy of 95%. The developer is a resident of "," SkolkovoDigital Oncomorphologist the company LLC "," which announced this on August 6, 2024.
In addition to recognizing the acinar adenocarcinoma itself, the solution allows you to calculate the sum of points on the Gleason scale (used to determine the degree of malignancy of the tumor). As well as the prognostic group of the patient, which is one of the key factors in choosing the optimal treatment.
The certificate is issued by risk class 3, this allows the platform to be used in medical organizations in processes for diagnosing diseases that have a large risk to health. In addition to prostate cancer, the company plans to bring cancer diagnosis solutions to the market in other organs as well.
We are pleased to announce the receipt of a marketing authorization for our artificial intelligence-based pathomorphology software. This is an important step forward for Russian medicine, which will help improve the quality of diagnosis and treatment of patients. Our company will continue to invest in the development of innovative solutions that contribute to improving healthcare in Russia and abroad, "said Gennady Popov, General Director of Digital Oncomorphologist LLC. |
The PathVision.ai platform includes both AI algorithms for analyzing medical images and all the necessary professional digital tools for the work of pathomorphologists.